HEMOCLOT DTI 2.5 (Direct Thrombin Inhibitors)
Description
Assay designed for the quantitative measurement of direct thrombin inhibitors (DTI), such as dabigatran and argatroban, in human citrated plasma, with a clotting method based on the inhibition of a constant and defined concentration of thrombin. It is intended for prescription use. Measuring DTI concentrations in patient’s plasma may be used as an aid in the management of patients receiving DTIs who are suspected of having excess anticoagulant activity.
Intended use
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.